These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3606645)
1. Effects of methoxsalen on the metabolism of acetaminophen in humans. Amouyal G; Larrey D; Letteron P; Geneve J; Labbe G; Belghiti J; Pessayre D Biochem Pharmacol; 1987 Jul; 36(14):2349-52. PubMed ID: 3606645 [TBL] [Abstract][Full Text] [Related]
2. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice. Letteron P; Descatoire V; Larrey D; DeGott C; Tinel M; Geneve J; Pessayre D J Pharmacol Exp Ther; 1986 Nov; 239(2):559-67. PubMed ID: 3772810 [TBL] [Abstract][Full Text] [Related]
3. The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice. Labbe G; Descatoire V; Letteron P; Degott C; Tinel M; Larrey D; Carrion-Pavlov Y; Geneve J; Amouyal G; Pessayre D Biochem Pharmacol; 1987 Mar; 36(6):907-14. PubMed ID: 3105541 [TBL] [Abstract][Full Text] [Related]
4. Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in mice. Lettéron P; Degott C; Labbe G; Larrey D; Descatoire V; Tinel M; Pessayre D Toxicol Appl Pharmacol; 1987 Nov; 91(2):266-73. PubMed ID: 3118512 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives. Tinel M; Belghiti J; Descatoire V; Amouyal G; Letteron P; Geneve J; Larrey D; Pessayre D Biochem Pharmacol; 1987 Mar; 36(6):951-5. PubMed ID: 3494453 [TBL] [Abstract][Full Text] [Related]
6. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety. Labbe G; Descatoire V; Beaune P; Letteron P; Larrey D; Pessayre D J Pharmacol Exp Ther; 1989 Sep; 250(3):1034-42. PubMed ID: 2506333 [TBL] [Abstract][Full Text] [Related]
7. Direct protection against acetaminophen hepatotoxicity by propylthiouracil. In vivo and in vitro studies in rats and mice. Yamada T; Ludwig S; Kuhlenkamp J; Kaplowitz N J Clin Invest; 1981 Mar; 67(3):688-95. PubMed ID: 7204554 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of acetaminophen activation by ethanol and acetaldehyde in liver microsomes. Sato C; Liu J; Miyakawa H; Nouchi T; Tanaka Y; Uchihara M; Marumo F Life Sci; 1991; 49(24):1787-91. PubMed ID: 1943482 [TBL] [Abstract][Full Text] [Related]
9. Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans. Mays DC; Camisa C; Cheney P; Pacula CM; Nawoot S; Gerber N Clin Pharmacol Ther; 1987 Dec; 42(6):621-6. PubMed ID: 3690940 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Zhang W; Kilicarslan T; Tyndale RF; Sellers EM Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760 [TBL] [Abstract][Full Text] [Related]
11. Effects of sulphur-containing compounds on paracetamol activation and covalent binding in a mouse hepatic microsomal system. Tredger JM; Smith HM; Davis M; Williams R Toxicol Lett; 1980 Apr; 5(5):339-44. PubMed ID: 7385255 [TBL] [Abstract][Full Text] [Related]
12. Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Pessayre D; Dolder A; Artigou JY; Wandscheer JC; Descatoire V; Degott C; Benhamou JP Gastroenterology; 1979 Aug; 77(2):264-71. PubMed ID: 109346 [TBL] [Abstract][Full Text] [Related]
13. Microsomal oxidative damage promoted by acetaminophen metabolism. Letelier ME; López-Valladares M; Peredo-Silva L; Rojas-Sepúlveda D; Aracena P Toxicol In Vitro; 2011 Oct; 25(7):1310-3. PubMed ID: 21569833 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of the preventive effect of ethanol on acetaminophen-induced hepatoxicity. Sato C; Lieber CS J Pharmacol Exp Ther; 1981 Sep; 218(3):811-5. PubMed ID: 7264963 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of cytochrome P-450 by the drug methoxsalen. Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man. Mitchell MC; Schenker S; Speeg KV J Clin Invest; 1984 Feb; 73(2):383-91. PubMed ID: 6142056 [TBL] [Abstract][Full Text] [Related]
17. Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo. Miller MG; Jollow DJ Drug Metab Dispos; 1984; 12(3):271-9. PubMed ID: 6145552 [TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031 [TBL] [Abstract][Full Text] [Related]
19. Interaction of caffeine with acetaminophen. 1. Correlation of the effect of caffeine on acetaminophen hepatotoxicity and acetaminophen bioactivation following treatment of mice with various cytochrome P450 inducing agents. Jaw S; Jeffery EH Biochem Pharmacol; 1993 Aug; 46(3):493-501. PubMed ID: 8347173 [TBL] [Abstract][Full Text] [Related]
20. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity. Kharasch ED; Hankins DC; Taraday JK Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]